Daré Bioscience, Inc. (DARE)
NASDAQ·Healthcare·Biotechnology
$1.20
+0.84%
Mkt Cap $14.57M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+904.2%
Consensus $12.00 vs current $1.20
NASDAQ·Healthcare·Biotechnology
$1.20
+0.84%
Mkt Cap $14.57M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+904.2%
Consensus $12.00 vs current $1.20